Hofseth Biocare ASA: HBC Annual Report 2018

Today, 15 March 2019, the Board of Directors approved the Annual Report for 2018. There are no significant changes compared to the fourth quarter report issued 8 February 2019.

Please find the Annual Report for 2018 and the CSR Report attached.

For further information, please contact:

Roger Hofseth, CEO of Hofseth BioCare ASA
Mob: +47 95147941
E-mail: rh@hofseth-as.no

Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Mob: +47 93632966
E-mail: joo@hofsethbiocare.no 

About Hofseth BioCare ASA:
HBC is a Norwegian biotech company that offers high-value ingredients and finished products for humans and pets. The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through an innovative hydrolysis technology, HBC is able to preserve the quality of salmon oil, proteins and calcium, prepared of fresh salmon off-cuts. HBC's objective is to contribute to the efficient use of marine resources and deliver quality products for ingredients and finished consumer products in the nutrition market.

HBC ingredients and product family includes OmeGo® and Brilliant™ Salmon Oil, ProGo® and CollaGo® Salmon protein hydrolysates, CalGo® and Nøre™ Marine Calcium, and PetGo™ partly hydrolysed protein.

Hofseth BioCare's headquarters are located in Ålesund, Norway with branches in Oslo, Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange Axess list with ticker "HBC". More information about Hofseth BioCare at www.hofsethbiocare.com and www.facebook.com/hofsethbiocare


This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachments

HBC CSR Report 2018
Hofseth BioCare Annual report 2018 ENG